Danielle Twum is making it her mission to educate the public about the cutting-edge research taking place at Roswell Park, and how these breakthroughs change the way we treat cancer. The third-year pre-doctoral candidate, studying immunology in Dr. Scott Abrams’ lab, spearheaded her efforts last fall with a compelling presentation at TEDxBuffalo, an independent, local version of TED Talks.
Roswell Park made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CIMAvax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CIMAvax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”
Amid a historic normalizing of relations between the United States and Cuba, a potentially game-changing step was recently taken in the field of lung cancer research.